Therapeutic plasma exchange in the management of immune checkpoint inhibitor-associated immune-related adverse effects: A review.

Onwuemene, Oluwatoyosi A; Nnoruka, Chizoba I; Patriquin, Christopher J; Connelly-Smith, Laura S

Onwuemene, Oluwatoyosi A; Nnoruka, Chizoba I; Patriquin, Christopher J; Connelly-Smith, Laura S.

Afiliación

Onwuemene OA; Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Nnoruka CI; Division of Hematology/Oncology, Sibley Memorial Hospital, Sibley Memorial Hospital John Hopkins University, Washington, DC, USA.
Patriquin CJ; Department of Medicine, Division of Medical Oncology & Hematology, University Health Network, University of Toronto, Toronto, ON, Canada.
Connelly-Smith LS; Department of Medicine, University of Washington and Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Transfusion ; 62(11): 2370-2390, 2022 11.

Article en En | MEDLINE | ID: mdl-36134464

Asunto(s)

Inhibidores de Puntos de Control Inmunológico; Neoplasias; Humanos; Intercambio Plasmático; Inmunoterapia; Neoplasias/tratamiento farmacológico; Plasmaféresis

Palabras clave

immune checkpoint inhibitors; immune-related adverse events; plasma exchange

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Transfusion Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google